Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Guardant Health, Inc. (GH : NSDQ)
 
 • Company Description   
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.

Number of Employees: 1,373

 
 • Price / Volume Information   
Yesterday's Closing Price: $34.75 Daily Weekly Monthly
20 Day Moving Average: 2,156,213 shares
Shares Outstanding: 101.92 (millions)
Market Capitalization: $3,541.83 (millions)
Beta: 0.70
52 Week High: $133.82
52 Week Low: $27.65
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -47.22% -40.55%
12 Week -47.03% -41.76%
Year To Date -65.26% -57.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3000 Hanover Street
-
Palo Alto,CA 94304
USA
ph: 855-698-8887
fax: 888-974-4258
investors@guardanthealth.com http://www.guardanthealth.com
 
 • General Corporate Information   
Officers
Helmy Eltoukhy - Co-Chief Executive Officer and Chairman of the Boa
AmirAli Talasaz - Co-Chief Executive Officer and Director
Michael Bell - Chief Financial Officer
Ian Clark - Director
Vijaya Gadde - Director

Peer Information
Guardant Health, Inc. (CORR.)
Guardant Health, Inc. (RSPI)
Guardant Health, Inc. (CGXP)
Guardant Health, Inc. (BGEN)
Guardant Health, Inc. (GTBP)
Guardant Health, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 40131M109
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 101.92
Most Recent Split Date: (:1)
Beta: 0.70
Market Capitalization: $3,541.83 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.25 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-4.76 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 10.83% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.64
Price/Cash Flow: -
Price / Sales: 9.06
EPS Growth
vs. Year Ago Period: -14.15%
vs. Previous Quarter: -35.96%
Sales Growth
vs. Year Ago Period: 22.16%
vs. Previous Quarter: -11.11%
ROE
03/31/22 - -62.68
12/31/21 - -53.91
09/30/21 - -44.55
ROA
03/31/22 - -18.94
12/31/21 - -17.77
09/30/21 - -17.76
Current Ratio
03/31/22 - 4.87
12/31/21 - 5.72
09/30/21 - 15.57
Quick Ratio
03/31/22 - 4.71
12/31/21 - 5.57
09/30/21 - 15.33
Operating Margin
03/31/22 - -107.20
12/31/21 - -107.82
09/30/21 - -117.99
Net Margin
03/31/22 - -107.20
12/31/21 - -108.57
09/30/21 - -118.80
Pre-Tax Margin
03/31/22 - -102.40
12/31/21 - -102.89
09/30/21 - -117.77
Book Value
03/31/22 - 5.23
12/31/21 - 6.34
09/30/21 - 6.98
Inventory Turnover
03/31/22 - 4.26
12/31/21 - 4.44
09/30/21 - 4.59
Debt-to-Equity
03/31/22 - 2.13
12/31/21 - 1.76
09/30/21 - 1.60
Debt-to-Capital
03/31/22 - 68.05
12/31/21 - 63.76
09/30/21 - 61.52
 

Powered by Zacks Investment Research ©